How Fast Does Spravato Work? Timeline, Results, and What to Expect

Introduction

For individuals living with treatment-resistant depression (TRD), one of the most common questions about Spravato® (esketamine) is how quickly it works. Unlike traditional antidepressants, which can take weeks to show meaningful improvement, Spravato is known for its rapid onset of action under supervised medical care.

In this guide, we explain how fast Spravato works, what the treatment timeline looks like, what patients may experience during early sessions, and how results are evaluated over time. At Sacramento NeuroPsych Associates, Spravato is offered as part of a comprehensive, evidence-based approach to depression care.

Why Spravato Works Faster Than Traditional Antidepressants

Most oral antidepressants target serotonin, norepinephrine, or dopamine systems and require gradual changes in brain chemistry over several weeks. Spravato works differently.

Spravato contains esketamine, which acts on the brain’s glutamate system, a key pathway involved in neural communication, mood regulation, and synaptic plasticity. By influencing NMDA receptors and promoting synaptic connectivity, Spravato may help restore neural pathways affected by depression more quickly than conventional medications.

Because of this unique mechanism, some patients report symptom relief within hours or days, rather than weeks.

Learn more about how Spravato works on the Spravato treatment page.

How Quickly Can Patients Feel Improvement?

Response times vary, but clinical studies and real-world experience show a general pattern:

• Within 24–72 hours:
  
  Some patients notice early changes in mood, reduced emotional heaviness, or improved clarity.
  
  
• Within the first 1–2 weeks:
  
  Many patients begin to experience more consistent symptom improvement during the induction phase.
  
  
• By weeks 4–6:
  
  Clinicians evaluate whether Spravato is producing sustained benefits and determine the appropriate maintenance schedule.
  
  

It’s important to note that not everyone responds at the same pace, and early improvement does not guarantee long-term response. Careful monitoring is essential.

You can compare this timeline with other FDA-approved therapies, like TMS therapy for depression.

What the Spravato Treatment Timeline Looks Like

Induction Phase (Weeks 1–4)

• Typically two treatments per week
  
  
• Administered in-clinic under medical supervision
  
  
• Each visit includes self-administration of the nasal spray and at least two hours of monitoring
  
  

Maintenance Phase (After Week 4)

• Frequency may decrease to weekly or biweekly, depending on symptom response
  
  
• Ongoing assessments guide treatment planning
  
  

Spravato is often used alongside an oral antidepressant initially, though in some cases it may be appropriate as monotherapy when clinically indicated (as discussed on the FDA-Approved Depression Treatments article).

What “Rapid Improvement” Really Means

Rapid improvement does not equate to instant remission. Instead, patients may notice:

• Reduced intensity of depressive symptoms
  
  
• Improved ability to engage in daily activities
  
  
• Less emotional numbness or hopelessness
  
  

Spravato should be viewed as a tool within a broader treatment plan, not a standalone cure. Long-term success depends on continual evaluation, supportive care, and individualized planning.

How Clinicians Measure Progress

At Sacramento NeuroPsych Associates, progress is evaluated using:

• Clinical interviews and symptom tracking
  
  
• Standardized depression rating scales
  
  
• Functional improvements (sleep, energy, daily functioning)
  
  
• Patient-reported experiences over time
  
  

If Spravato does not produce meaningful improvement after a full induction phase, clinicians may recommend alternative or adjunctive treatments.

For comparison with other non-medication alternatives, learn about TMS therapy.

Safety, Monitoring, and Expectations

Because Spravato can cause temporary side effects such as dissociation, dizziness, or sedation, it is only administered in certified clinical settings. Patients:

• Must remain under observation for at least two hours after dosing
  
  
• Cannot drive or operate machinery until the next day
  
  
• Are monitored for blood pressure changes and other safety factors
  
  

Most side effects occur shortly after dosing and resolve the same day.

You can review common side effect profiles on the Spravato service page.

Who May Benefit Most From Spravato

Spravato is typically considered for adults who:

• Have not responded adequately to two or more antidepressants
  
  
• Require faster symptom relief than traditional medications provide
  
  
• Can commit to supervised, in-clinic treatment visits
  
  

A comprehensive psychiatric evaluation is required to determine eligibility.

How Spravato Fits Into a Comprehensive Care Plan

Spravato is often combined with:

• Ongoing psychiatric medication management
  
  
• Psychotherapy
  
  
• Lifestyle and supportive interventions
  
  

This integrated approach helps maximize both short-term relief and long-term outcomes.

Learn more about scheduling Spravato treatment at Schedule an Appointment.

Frequently Asked Questions

How fast does Spravato start working?

Some patients notice improvement within the first few days, though full response is evaluated over several weeks.

Is Spravato faster than traditional antidepressants?

Yes. Spravato’s mechanism allows for more rapid symptom relief compared to medications that require weeks to take effect.

Does everyone respond quickly to Spravato?

No. Response varies, and some patients may require additional time or alternative treatments.

Is Spravato a long-term treatment?

For some patients, yes. Others may taper treatment once symptoms stabilize, under medical guidance.

‍